上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1323Please respect copyright.PENANABAuWeccsR1
1323Please respect copyright.PENANAgU3G2Qzajy
上集:https://www.penana.com/article/4711251323Please respect copyright.PENANAALtswPrknk
1323Please respect copyright.PENANAXfeFmTN3ry1323Please respect copyright.PENANAA74nJCtMZK
1323Please respect copyright.PENANALcx3gOiRzd
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1323Please respect copyright.PENANASRvEkZc5ed
1323Please respect copyright.PENANAVdxZ2H7qn4
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1323Please respect copyright.PENANA1X8E4WhKqe
1323Please respect copyright.PENANAq9yQ87r2Q6
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1323Please respect copyright.PENANATTH6OBW2Dd
1323Please respect copyright.PENANAVo9cFLxSXQ1323Please respect copyright.PENANAEH8sBuQNrp
1323Please respect copyright.PENANABel26oSXjv
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1323Please respect copyright.PENANA9NcuqwUfQK
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1323Please respect copyright.PENANA3tBVq73TiJ
1323Please respect copyright.PENANAfnhqBqnMJF
忘記甚麼是Neoantigen的話,可重溫上一集。1323Please respect copyright.PENANA6OJkjLjSUA
1323Please respect copyright.PENANADPR3l8aZDY
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1323Please respect copyright.PENANAFwJzLBabfE
1323Please respect copyright.PENANAK2WSyyckfe
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1323Please respect copyright.PENANAIWnr9tgWiB
1323Please respect copyright.PENANAI2cKFyvTU81323Please respect copyright.PENANA9B5WQs7K4E
1323Please respect copyright.PENANAQV7LuiIveT
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1323Please respect copyright.PENANAzRQrdxkL6N
1323Please respect copyright.PENANAhM8PTLl1Af
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1323Please respect copyright.PENANA8opIaUIisB
1323Please respect copyright.PENANArtgq3djSYn
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1323Please respect copyright.PENANAgFfnzYrGrj1323Please respect copyright.PENANAidGfsOtl9g
1323Please respect copyright.PENANAVf5IfEAeBH
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1323Please respect copyright.PENANAvMZ3GhlgZF
1323Please respect copyright.PENANAqoHRe1XVQ0
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1323Please respect copyright.PENANAbN7RTVgq3J1323Please respect copyright.PENANAx6zMxZ6GYX
1323Please respect copyright.PENANAtFv8U0Tih1
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1323Please respect copyright.PENANA8Yj89QZInC
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1323Please respect copyright.PENANAc1OGKqRRgg
1323Please respect copyright.PENANArZXDJ76wtn
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1323Please respect copyright.PENANAaYDVEi427w
1323Please respect copyright.PENANAB7eE1FNBno
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1323Please respect copyright.PENANAuvGlkmgipU
1323Please respect copyright.PENANAZ6lNfXcDEk
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1323Please respect copyright.PENANAk4jfwSosy8
1323Please respect copyright.PENANAb94Ryeaufq
1323Please respect copyright.PENANAP0fSbpvZAn
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1323Please respect copyright.PENANAcRrrfvX6s9
1323Please respect copyright.PENANAu4CtIceKXW
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1323Please respect copyright.PENANA1MKuoQGQQR
1323Please respect copyright.PENANATDH8xM1rXq
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1323Please respect copyright.PENANAByrfKQi2HE
1323Please respect copyright.PENANAug4sByMzkI
Link:1323Please respect copyright.PENANA3PC8qz9pCx
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1323Please respect copyright.PENANALAD7k4vTDy
1323Please respect copyright.PENANA0GuuH1FxIn
1323Please respect copyright.PENANAePDINIows0
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1323Please respect copyright.PENANAyEH61OjAT3